Company Joincare Pharmaceutical Group Industry Co.,Ltd.
Equities
600380
CNE000001816
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12 CNY | +0.08% | +2.83% | -3.46% |
Apr. 18 | Joincare Pharma Says Flu Drug Phase 3 Trial Attains Primary Endpoint | MT |
Apr. 18 | Joincare Pharmaceutical Successfully Completes TG-1000 Phase III Study | CI |
Business Summary
Number of employees: 14,365
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Chemical Pharmaceuticals
52.3
%
| - | - | 8,714 | 52.3 % | - |
Chemical Active Pharmaceutical Ingredients and Intermediates
30.3
%
| 5,230 | 30.5 % | 5,045 | 30.3 % | -3.52% |
Traditional Chinese Drug Preparation Products
10.8
%
| 1,297 | 7.6 % | 1,805 | 10.8 % | +39.24% |
Diagnostic Reagents and Equipment
4.0
%
| 724 | 4.2 % | 659 | 4.0 % | -8.92% |
Health Care Product
1.2
%
| 121 | 0.7 % | 196 | 1.2 % | +61.56% |
Biological Product
0.5
%
| - | - | 84 | 0.5 % | - |
Other Operations
0.4
%
| 130 | 0.8 % | 63 | 0.4 % | -51.90% |
Sales Materials, Processing Fees, Etc.
0.3
%
| - | - | 49 | 0.3 % | - |
Others
0.1
%
| 0 | 0.0 % | 17 | 0.1 % | +16,729.80% |
Rental Fees
0.1
%
| - | - | 13 | 0.1 % | - |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
84.4
%
| 14,171 | 83.3 % | 13,938 | 84.4 % | -1.64% |
Overseas
15.6
%
| 2,842 | 16.7 % | 2,584 | 15.6 % | -9.09% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Xiong Yu
PSD | President | 63 | 21-08-26 |
Qing Feng Qiu
DFI | Director of Finance/CFO | 53 | 12-08-27 |
Zhi Wei Xing
BRD | Director/Board Member | 38 | - |
Nan Qi Lin
BRD | Director/Board Member | 42 | 18-08-27 |
Jin Hua Peng
BRD | Director/Board Member | 62 | 12-08-27 |
Xian Zhou
IRC | Investor Relations Contact | - | - |
Leiming Zhang
PRN | Corporate Officer/Principal | - | 23-08-08 |
Zhao Fengguang
SEC | Corporate Secretary | - | - |
Feng Guang Zhao
SEC | Corporate Secretary | 49 | 16-10-25 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bao Guo Zhu
FOU | Founder | 62 | 92-12-17 |
Guang Xia Liu
BRD | Director/Board Member | 55 | 12-08-27 |
Qing Feng Qiu
DFI | Director of Finance/CFO | 53 | 12-08-27 |
Xiao Yun Yu
CHM | Chairman | 56 | 12-08-27 |
Xiong Yu
PSD | President | 63 | 21-08-26 |
Jin Hua Peng
BRD | Director/Board Member | 62 | 12-08-27 |
Feng Guang Zhao
SEC | Corporate Secretary | 49 | 16-10-25 |
Juan Peng
BRD | Director/Board Member | 59 | 21-08-26 |
Nan Qi Lin
BRD | Director/Board Member | 42 | 18-08-27 |
Ye Zhi Tan
BRD | Director/Board Member | 50 | 20-05-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,866,634,764 | 921,886,520 ( 49.39 %) | 0 | 49.39 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
255,513,953 | 42.20% | 1,290,394,010 $ | |
40,662,579 | 2.11% | 61,268,748 $ |
Company contact information
Joincare Pharmaceutical Group Industry Co., Ltd.
Joincare Pharmaceutical Grp Bldg 17 Langshan Road
518057, Shenzhen
+86 75 5862 52368
http://www.joincare.comSector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.46% | 3.09B | |
+26.09% | 653B | |
+27.00% | 556B | |
-6.61% | 354B | |
+20.95% | 331B | |
+2.52% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-5.90% | 144B |
- Stock Market
- Equities
- 600380 Stock
- Company Joincare Pharmaceutical Group Industry Co.,Ltd.